Melo Andréia Cristina de, Lopes da Silva Jessé, Paulino Eduardo, Ingles Russo Garces Álvaro, Mendes Sofia Vidaurre, Lino da Silva Flora de Moraes, Lopes David Bruna Bianca, Dos Santos Alexssandra Lima Siqueira, Santos Thuler Luiz Claudio
Division of Clinical Research and Technological Development, Brazilian National Cancer Institute, Rio de Janeiro, Brazil.
Drug Development Unit, The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, London, United Kingdom.
JCO Glob Oncol. 2025 Mar;11:e2400604. doi: 10.1200/GO-24-00604. Epub 2025 Mar 20.
This study aimed to examine trends in the incidence and mortality rates of endometrial cancer (EC) across ethnic groups in Brazil and to analyze the demographic and clinicopathological characteristics associated with these trends.
The incidence of EC was analyzed from 2010 to 2015 using data from Brazilian Population-Based Cancer Registries (PBCRs), including crude rates and annual percentage changes (APCs). Clinical and sociodemographic information from 2000 to 2019 was gathered from Hospital-Based Cancer Registries. Mortality data between 2000 and 2021 were obtained from the National Mortality Information System, allowing for comparisons between White women and Black women.
From 2010 to 2015, a total of 32,831 new cases of EC were reported across 13 PBCRs, with Black patients accounting for 35.7% of these cases. The median age at diagnosis was 63 years, with Black women diagnosed at a younger age than White women. Black patients experienced a significant increase in incidence rate (APC +6.7% +3.0%). A greater proportion of Black patients lived without partners (54.0%), had higher rates of alcohol consumption (15%) and smoking (25.8%), and resided in less developed regions (54.6%) with lower education levels (77.5%). From 2000 to 2021, Brazil recorded 72,189 EC-related deaths, showing higher mortality rates among White women (3.8 per 100,000) than Black women (2.4 per 100,000), although the downward trend was steeper among White women (-1.2%) than Black women (-0.6%).
Racial disparities in EC incidence and mortality in Brazil may be closely linked to unfavorable sociodemographic factors faced by Black women. Targeted public health initiatives are critical for improving early detection and access to equitable care for Black women.
本研究旨在调查巴西不同种族子宫内膜癌(EC)的发病率和死亡率趋势,并分析与这些趋势相关的人口统计学和临床病理特征。
利用巴西基于人群的癌症登记处(PBCRs)的数据,分析2010年至2015年EC的发病率,包括粗发病率和年度百分比变化(APC)。2000年至2019年的临床和社会人口学信息来自基于医院的癌症登记处。2000年至2021年的死亡率数据来自国家死亡率信息系统,以便对白种女性和黑种女性进行比较。
2010年至2015年,13个PBCRs共报告了32831例新的EC病例,其中黑人患者占这些病例的35.7%。诊断时的中位年龄为63岁,黑人女性的诊断年龄比白人女性年轻。黑人患者的发病率显著增加(APC +6.7% +3.0%)。更大比例的黑人患者没有伴侣(54.0%),饮酒率(15%)和吸烟率(25.8%)较高,居住在欠发达地区(54.6%),教育水平较低(77.5%)。2000年至2021年,巴西记录了72189例与EC相关的死亡,白种女性的死亡率(每10万人3.8例)高于黑种女性(每10万人2.4例),尽管白种女性的下降趋势(-1.2%)比黑种女性(-0.6%)更陡峭。
巴西EC发病率和死亡率的种族差异可能与黑人女性面临的不利社会人口学因素密切相关。有针对性的公共卫生举措对于改善黑人女性的早期检测和获得公平医疗至关重要。